-
From the Editor-in-Chief
COVID-19 and Cancer in 2022Is it the beginning of the end or the end of the beginning?
by William G. Nelson, MD, PhD
-
Policy Matters
Patient Advocacy Is Driving ChangePatient advocates strengthen every aspect of research, from funding innovative science and informing research design, to leading efforts on Capitol Hill to build support for research.
by Carrie Treadwell, MBA
-
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
-
The Impact of the RACE for Children ActLegislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
-
Making Collaboration More Common for Rare CancersAn AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
by Marci A. Landsmann
-
Medicaid: A Partial Safety NetExpansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.
by Sharon Tregaskis
-
Forward Look
Adequate RepresentationMedical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.
by Erin O'Donnell
-
Get Involved
Doing Yoga in RecoveryA volunteer program brings yoga to cancer patients in the hospital.
by Bradley Jones
-
Facts and Stats
Fifty Years of Growing SurvivorshipMore people in the U.S. are alive after being diagnosed with cancer than ever before.
by Eric Fitzsimmons
-
Policy Matters
Cancer Research: The Key to Tomorrow’s CuresThe AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.
by David A. Tuveson, MD, PhD
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
